Our results showed that the expression of PD-L1 (P = 0.011) and high expression of α-SMA (P=0.025) were associated with a significant reduction in the DFS of the patients with resectable colorectal cancer, similar to the results reported previously (41–45). This evidence concerns the gene ACTA1 and colorectal cancer.